Baj Z - Search Results

1

The influence of hyperlipidemia on platelet activity markers in patients after ischemic stroke.

Pawelczyk M, Baj Z, Chmielewski H, Kaczorowska B, Klimek A. Pawelczyk M, et al. Among authors: baj z. Cerebrovasc Dis. 2009;27(2):131-7. doi: 10.1159/000177920. Epub 2008 Nov 28. Cerebrovasc Dis. 2009. PMID: 19047793

2

Platelet Reactivity in Patients With Stroke and Hyperlipidemia, GPIbα Assessment.

Pawelczyk M, Chmielewski H, Kaczorowska B, Przybyła M, Baj Z. Pawelczyk M, et al. Among authors: baj z. Clin Appl Thromb Hemost. 2016 Mar;22(2):166-70. doi: 10.1177/1076029614543823. Epub 2014 Jul 25. Clin Appl Thromb Hemost. 2016. PMID: 25063764 Free article.

3

The influence of statin therapy on platelet activity markers in hyperlipidemic patients after ischemic stroke.

Pawelczyk M, Chmielewski H, Kaczorowska B, Przybyła M, Baj Z. Pawelczyk M, et al. Among authors: baj z. Arch Med Sci. 2015 Mar 16;11(1):115-21. doi: 10.5114/aoms.2015.49216. Epub 2015 Mar 14. Arch Med Sci. 2015. PMID: 25861297 Free PMC article.

4

The impact of hyperglycemia and hyperlipidemia on plasma P-selectin and platelet markers after ischemic stroke.

Pawelczyk M, Kaczorowska B, Baj Z. Pawelczyk M, et al. Among authors: baj z. Arch Med Sci. 2017 Aug;13(5):1049-1056. doi: 10.5114/aoms.2017.65816. Epub 2017 Feb 1. Arch Med Sci. 2017. PMID: 28883845 Free PMC article.

5

sP- and sE-selectin in stroke patients with metabolic disorders.

Pawelczyk M, Glabiński A, Kaczorowska B, Baj Z. Pawelczyk M, et al. Among authors: baj z. Neurol Neurochir Pol. 2018 Sep-Oct;52(5):599-605. doi: 10.1016/j.pjnns.2018.08.004. Epub 2018 Aug 17. Neurol Neurochir Pol. 2018. PMID: 30190210

6

Fibrinogen concentrations in ischaemic stroke patients with metabolic disorders.

Pawelczyk M, Kaczorowska B, Baj Z. Pawelczyk M, et al. Among authors: baj z. Neurol Neurochir Pol. 2020;54(3):259-264. doi: 10.5603/PJNNS.a2020.0035. Epub 2020 Apr 15. Neurol Neurochir Pol. 2020. PMID: 32293697

7

Surface markers of platelet function in idiopathic nephrotic syndrome in children.

Tkaczyk M, Baj Z. Tkaczyk M, et al. Among authors: baj z. Pediatr Nephrol. 2002 Aug;17(8):673-7. doi: 10.1007/s00467-002-0865-7. Epub 2002 May 17. Pediatr Nephrol. 2002. PMID: 12185480 Clinical Trial.

8

Cyclosporin A does not affect platelets in children with idiopathic nephrotic syndrome.

Tkaczyk M, Baj Z, Nowicki M. Tkaczyk M, et al. Among authors: baj z. Pediatr Nephrol. 2005 Jan;20(1):30-5. doi: 10.1007/s00467-004-1674-y. Epub 2004 Oct 28. Pediatr Nephrol. 2005. PMID: 15517412

9

[Platelet activation in relapse idiopathic nephrotic syndrome in children].

Tkaczyk M, Baj Z, Nowicki M. Tkaczyk M, et al. Among authors: baj z. Pol Merkur Lekarski. 2001 Apr;10(58):229-32. Pol Merkur Lekarski. 2001. PMID: 11434163 Clinical Trial. Polish.

10

Platelet reactivity and mean platelet volume as risk markers of thrombogenesis in atrial fibrillation.

Makowski M, Smorag I, Makowska J, Bissinger A, Grycewicz T, Paśnik J, Kidawa M, Lubiński A, Zielińska M, Baj Z. Makowski M, et al. Among authors: baj z. Int J Cardiol. 2017 May 15;235:1-5. doi: 10.1016/j.ijcard.2017.03.023. Epub 2017 Mar 9. Int J Cardiol. 2017. PMID: 28302320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page